Skip to content

Insider · CIK 0001384550

Michael H Tardugno

chairofficerdirector

Files at IMNN (Imunon, Inc.). First filing -, latest -.

Michael H Tardugno files SEC Form 4 as chair and director at IMNN (Imunon, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Michael H Tardugno has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 11 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 25, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+7,169$1.41$10k103,92115 d ago
Sep 11, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+5,824$1.47$8,56195,69928 d ago
Aug 28, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+7,371$1.60$12k89,87542 d ago
Jun 25, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+42,519$1.72$73k59,986Jun 29, 2026
Jun 18, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+4,629$1.82$8,42517,467Jun 23, 2026
Jun 5, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+4,089$2.06$8,42312,838Jun 9, 2026
May 22, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+3,484$2.20$7,6658,749May 27, 2026
Jan 2, 2026IMNN
Imunon, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+43,821$0.00$043,821Jan 6, 2026
Aug 4, 2025IMNN
Imunon, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+1,667$0.00$01,667Aug 6, 2025
Mar 14, 2025IMNN
Imunon, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+25,000$0.00$025,000Mar 18, 2025
Dec 18, 2024IMNN
Imunon, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+12,500$0.00$012,500Dec 19, 2024

Questions about Michael H Tardugno

Answered from the filings on this page, as of the latest one.

Is Michael H Tardugno buying or selling?

Michael H Tardugno has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Michael H Tardugno's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael H Tardugno has 0.

Where does Michael H Tardugno file Form 4?

Michael H Tardugno has filed Form 4 at IMNN (Imunon, Inc.) as Executive Chairman of Board. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael H Tardugno: insider trades and track record | InsiderTell